Best Tirzepatide Providers
Tirzepatide is the more expensive molecule, and the gap widens as you titrate. A provider that looks cheap at a starting dose can be the costliest option by the time you reach maintenance, so this ranking pays particular attention to what happens at higher doses.
Fewer providers offer compounded tirzepatide than compounded semaglutide — several platforms that advertise "$99 GLP-1s" have no affordable tirzepatide route at all. Where that is the case, we say so.
Transparency: We earn commissions from some providers listed here. Rankings are built from each provider's own published pricing and policies, verified August 5, 2026, and every entry lists a drawback. Full disclosure →
At a Glance
| # | Provider | Price | What that covers | Best for |
|---|---|---|---|---|
| 1 | LillyDirect | $299–$699/mo | FDA-approved medication, no membership | Approved tirzepatide, cash-pay |
| 2 | Ivím Health | $75/mo + $133 | Membership plus compounded tirzepatide | Lowest compounded price |
| 3 | Walgreens Weight Management | $49/visit + medication | Per-visit care; no subscription | Approved tirzepatide + prescriber |
| 4 | Mochi Health | ~$278/mo | $79 membership + $199 compounded tirzepatide | Compounded with support |
| 5 | Found | $99/mo + visits | Compounded medication; care billed per visit | Insured tirzepatide access |
| 6 | PlushCare | $19.99/mo + visits | Membership; medication billed at pharmacy | In-network video care |
| 7 | LifeMD | $149/mo + $349 | Membership including labs, plus medication | Zepbound plus labs |
| 8 | WeightWatchers Med+ | $74/mo + medication | Membership only — medication excluded | FDA-approved only |
Prices as published by each provider on August 5, 2026. Telehealth pricing changes frequently — confirm on the provider's own site before committing.
How We Ranked These
We read each provider's published pages and recorded what they actually state about medications, pricing, eligibility, and policies. Where a company does not publish something, we treat that as a finding rather than filling the gap with an estimate.
Cost across the full dose range
Not just the starting price. Where a provider publishes dose-by-dose pricing we use it, because maintenance dosing is where most of the money goes.
Whether tirzepatide is genuinely available
Several providers list brand-name Zepbound and Mounjaro but only compound semaglutide. If the affordable route excludes tirzepatide, that is a material limitation.
Total published cost
Medication plus membership, from month two onward. Advertised "from" figures with unstated second halves do not count.
Regulatory status, stated plainly
Whether the provider is clear about FDA-approved versus compounded, and whether the disclosure is accurate rather than softened.
Continuity terms
Refill windows, fill caps, and commitment lengths. Tirzepatide titration runs over months, and terms that penalise a missed refill matter more here than anywhere.
What we could not assess
- •We reviewed published pages rather than enrolling, so clinician quality, response times, and fulfilment reliability are outside what we can assess.
- •LillyDirect self-pay pricing carries a stated card expiry of December 31, 2026, an 11-fill annual cap, and a 45-day refill window at 7.5 mg and above.
- •Compounded tirzepatide prices are "starting at" figures for low doses. Almost no provider publishes a full titration schedule, so higher-dose compounded costs are largely unknown to us.
- •Whether tirzepatide or semaglutide suits you is a clinical decision. Do not choose a molecule because a pharmacy is cheaper.
- •Providers that publish no pricing at all — Henry Meds, Form Health, Fridays, Alloy — could not be ranked on cost.
LillyDirect
Best overall for tirzepatide
Why it ranks here
Eli Lilly selling its own Zepbound at published per-dose prices with no membership fee. This is the reference price for tirzepatide — genuine FDA-approved medication, manufacturer supply chain end to end, and every condition published in full including the unflattering ones. Nothing else offers approved tirzepatide anywhere near this price.
The catch
The price climbs sharply with titration: $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg, and $699 from 10 mg upward. The 11-fill annual cap against 28-day months does not cover a full year, the 45-day refill window applies at 7.5 mg and above, and you must supply your own prescriber.
Ivím Health
Cheapest compounded tirzepatide
Why it ranks here
The lowest published compounded tirzepatide price we found — $133/month on a six-month package, roughly $208 all-in with the $75 membership. That is about $70 under Mochi and $91 under FDA-approved Zepbound at its starting dose. Unlimited same-day visits with a matched board-certified provider are included, and the formulary also carries brand-name Zepbound and Mounjaro if you switch.
The catch
The price requires a six-month medication commitment of roughly $798 with no published cancellation or refund terms. Compounded tirzepatide is the only price Ivím publishes at all.
Walgreens Weight Management
Best route to Zepbound with a prescriber included
Why it ranks here
Zepbound KwikPens through a Lilly offer, plus a clinician at $49 a visit and no monthly subscription. Crucially, Walgreens publishes what the offer becomes afterward — $399 to $449 per month for subsequent doses — which is the number that determines what maintenance dosing actually costs.
The catch
FDA-approved only, so no compounded alternative. Each visit is $49, the Lilly offer expires December 31, 2026, and Walgreens does not publish eligibility criteria or which states it serves.
Mochi Health
Best compounded tirzepatide program
Why it ranks here
One of the few providers that actually compounds tirzepatide rather than only semaglutide, with both prices published so you can verify the $278 all-in figure before enrolling. Includes unlimited clinician messaging and registered dietitian access, and states plainly that compounded medications are not FDA-evaluated.
The catch
At $278 all-in you are paying only $21 less than FDA-approved Zepbound at its starting dose — a thin margin for a product that has not been evaluated by the FDA. Diagnostic services are excluded with no stated cost.
Found
Best if you have insurance
Why it ranks here
Lists compounded tirzepatide alongside brand-name Zepbound and Mounjaro with self-pay prices published for both — roughly $650+ for Zepbound and $1,100 for Mounjaro. Contracts with carriers directly and quotes a $50/month Medicare Part D copay, which no cash price can match.
The catch
The $99 starting figure covers compounded GLP-1s generally; per-visit clinical billing on top makes the total variable. No insurance plans in California, and no published eligibility criteria.
PlushCare
Best insured route to Zepbound
Why it ranks here
Prescribes Zepbound and Mounjaro through a conventional in-network relationship with Aetna, Humana and Cigna, with same-day video appointments. Publishes its eligibility criteria — BMI 30, or 27 with a comorbidity — so you know where you stand before spending anything.
The catch
No compounded pathway at all, and PlushCare's own estimate for uninsured patients is roughly $1,000/month. Prior authorisation for branded medication takes 7–14 business days.
LifeMD
Best for Zepbound with lab work included
Why it ranks here
Lists Zepbound in both vial and KwikPen form from $349/month self-pay, with comprehensive metabolic testing bundled into the membership if you have not been tested in twelve months. The benefits team handles prior authorisation paperwork.
The catch
Around $498/month all-in, well above buying Zepbound direct from Lilly at $299 for the same starting dose. Medicare, Medicaid and TRICARE patients are excluded outright, and membership fees are non-refundable.
WeightWatchers Med+
Best brand-name-only program
Why it ranks here
Offers Zepbound and refuses to prescribe compounded GLP-1s at all, which is a coherent safety position. The $74 membership buys clinical care, a mature behavioural program, and near-24/7 care team access for insurance work.
The catch
Medication is excluded entirely from the fee, with no compounded fallback if coverage is denied. Six- and twelve-month commitments with unpublished cancellation terms make an insurance denial an expensive outcome.
Which One Fits Your Situation?
A ranking is an average, and nobody is average. These are the situations where the top pick is the wrong answer.
You are paying cash and want Zepbound
LillyDirect, without much competition. $299/month at the starting dose direct from the manufacturer, no membership. Add a cheap prescriber if you need one.
You expect to reach a maintenance dose of 10 mg or higher
Budget for $699/month through LillyDirect and compare that against a compounded program before you start. This is where the tirzepatide cost curve bites hardest.
You want compounded tirzepatide specifically
Fewer providers offer it than offer compounded semaglutide. Ivím Health is cheapest at $133/month on a six-month package; Mochi Health, Found and Lemonaid Health also list it. Eden and Zealthy compound semaglutide only.
You cannot guarantee refilling on schedule
LillyDirect's 45-day refill window at 7.5 mg and above is a real risk if travel, illness, or supply issues intervene. A subscription program with automatic refills may suit you better despite the higher price.
You are deciding between tirzepatide and semaglutide
Tirzepatide produced greater average weight loss in trials, but costs more and has its own side effect profile. Compare both before locking into a provider.
You want to understand the medication itself first
Our tirzepatide guide covers the dual GIP/GLP-1 mechanism, the SURMOUNT and SURPASS trial results, dosing, and side effects.
Frequently Asked Questions
What is the cheapest way to get tirzepatide?+
For FDA-approved Zepbound, LillyDirect at $299/month for the 2.5 mg starting dose with no membership fee is the cheapest published route. For compounded tirzepatide, Mochi Health lists it from $199/month plus a $79 membership, giving roughly $278 all-in — only about $21 less than the approved product.
Why is tirzepatide more expensive than semaglutide?+
It is a newer, more complex molecule and it is priced higher across the board. Through the manufacturer channels, semaglutide starts at $149–$199/month while tirzepatide starts at $299 and rises to $699 at higher doses. Compounded tirzepatide follows the same pattern, typically $199 against $99 for compounded semaglutide.
Does the price go up as I increase my dose?+
Through LillyDirect, substantially: $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg, and $699 at 10 mg, 12.5 mg and 15 mg. Compounded providers generally advertise starting-dose prices without publishing the full schedule, so ask before you begin titrating.
Which providers offer compounded tirzepatide?+
Fewer than offer compounded semaglutide. Ivím Health lists it at $133/month on a six-month package, Mochi Health from $199/month, and Found and Lemonaid Health both include it among their compounded options. Eden and Zealthy list compounded semaglutide but not tirzepatide, so their cheapest advertised prices do not apply if tirzepatide is what you want.
What is the 45-day refill rule at LillyDirect?+
For doses of 7.5 mg and above, Lilly states you must complete your refill purchase within 45 days of the previous fill's delivery date to maintain pricing eligibility. There is no stated restriction at 2.5 mg and 5 mg. If continuity is a risk for you, factor this in before titrating up.
Is Zepbound the same as Mounjaro?+
Both are tirzepatide from Eli Lilly. Zepbound is approved for chronic weight management and obstructive sleep apnea in adults with obesity; Mounjaro is approved for type 2 diabetes. Which one your prescriber writes depends on your diagnosis, and it affects both coverage and self-pay pricing.
🇺🇸Medical Disclaimer
Your health, your doctor. This ranking is information about services, not medical advice, and we are researchers rather than clinicians. GLP-1 medications are prescription drugs requiring physician oversight and are not appropriate for everyone. Which medication suits you — if any — is a decision for you and your healthcare provider, not a function of which company ranks first here. Individual responses vary significantly. Verified August 5, 2026.